Cargando…

Pretreatment fibrinogen levels are associated with survival outcome in patients with cancer using immunotherapy as a second‑line treatment

The present study aimed to investigate the predictive value of pretreatment fibrinogen (FIB) levels in patients with cancer who received immunotherapy as a second-line treatment. A total of 61 patients with stage III–IV cancer were included. The cut-off value of FIB for predicting overall survival (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Rui, Yang, Tao, Yan, Bing, You, Junhao, Li, Fang, Zuo, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193380/ https://www.ncbi.nlm.nih.gov/pubmed/37216167 http://dx.doi.org/10.3892/ol.2023.13855

Ejemplares similares

Pretreatment elevated fibrinogen level predicts worse oncologic outcomes in upper tract urothelial carcinoma
por: Xu, Hang, et al.
Publicado: (2019)

Fibrinogen–Albumin Ratio Index (FARI) as a Certain Prognostic Biomarker in Pretreated Patients with Immunotherapy
por: Guo, Ziwei, et al.
Publicado: (2021)

Pretreatment plasma fibrinogen level as a prognostic biomarker for patients with lung cancer
por: Zhang, Yi, et al.
Publicado: (2020)

Evaluation of cumulative prognostic score based on pretreatment plasma fibrinogen and serum albumin levels in patients with newly diagnosed high-grade gliomas
por: He, Zhen-Qiang, et al.
Publicado: (2017)

Prognostic significance of pretreatment plasma fibrinogen in patients with hepatocellular and pancreatic carcinomas: A meta-analysis
por: Ji, Rui, et al.
Publicado: (2018)

Pretreatment albumin/fibrinogen ratio as a promising predictor for the survival of advanced non small-cell lung cancer patients undergoing first-line platinum-based chemotherapy
por: Ying, Jun, et al.
Publicado: (2019)

High fibrinogen levels are associated with poor survival in patients with liposarcoma
por: Peschek, L. S., et al.
Publicado: (2023)

Pretreatment plasma fibrinogen and serum albumin levels predict therapeutic efficacy of concurrent radiochemotherapy for esophageal squamous cell cancer
por: Wang, Jijin, et al.
Publicado: (2022)

The prognostic value of pretreatment albumin-to-fibrinogen ratio in small cell lung cancer patients receiving first-line platinum-based chemotherapy
por: Li, Qi, et al.
Publicado: (2023)

Impact of the pretreatment prognostic nutritional index on the survival after first‐line immunotherapy in non‐small‐cell lung cancer patients
por: Oku, Yuka, et al.
Publicado: (2023)

Elevated Pretreatment Fibrinogen-to-Lymphocyte Percentage Ratio Predict Tumor Staging and Poor Survival in Non-Small Cell Lung Cancer Patients with Chemotherapy or Surgery Combined with Chemotherapy
por: Liu, Meifang, et al.
Publicado: (2021)

Prognostic Impact of Pretreatment Plasma Fibrinogen in Patients with Locally Advanced Oral and Oropharyngeal Cancer
por: Holzinger, Daniel, et al.
Publicado: (2016)

A pretreatment transcriptomic signature that predicts outcomes of immunotherapy in melanoma
por: Hu, Junjie, et al.
Publicado: (2022)

Higher Plasma Fibrinogen Levels are Associated with Malignant Phenotype and Worse Survival in Patients with Glioblastomas
por: Wang, Peng-Fei, et al.
Publicado: (2018)

The Sustained Increase of Plasma Fibrinogen During Ischemic Stroke Predicts Worse Outcome Independently of Baseline Fibrinogen Level
por: Swarowska, Marta, et al.
Publicado: (2014)

The Prognostic Value of Pretreatment Plasma Fibrinogen in Urological Cancers: A Systematic Review and Meta-analysis
por: Song, Haifeng, et al.
Publicado: (2019)

Immunotherapy combined with rh-endostatin improved clinical outcomes over immunotherapy plus chemotherapy for second-line treatment of advanced NSCLC
por: Huang, Hongxiang, et al.
Publicado: (2023)

FOLFOX as second-line chemotherapy in patients with pretreated metastatic pancreatic cancer from the FIRGEM study
por: Zaanan, Aziz, et al.
Publicado: (2014)

Targeting fibrinogen-like protein 1 enhances immunotherapy in hepatocellular carcinoma
por: Lin, Mingen, et al.
Publicado: (2023)

Prognostic value of pretreatment plasma fibrinogen in patients with colorectal cancer: A systematic review and meta-analysis
por: Li, Menglei, et al.
Publicado: (2019)

Preoperative prealbumin-to-fibrinogen ratio to predict survival outcomes in hepatocellular carcinoma patients after hepatic resection
por: Yan, Haixi, et al.
Publicado: (2022)

Controversies in NSCLC: which second-line strategy after chemo-immunotherapy?
por: Moliner, L., et al.
Publicado: (2023)

Fibrinogen, Fibrinogen-like 1 and Fibrinogen-like 2 Proteins, and Their Effects
por: Sulimai, Nurul H., et al.
Publicado: (2022)

Docetaxel Monotherapy as Second-Line Treatment for Pretreated Advanced Non-Small Cell Lung Cancer Patients
por: Ko, Yoon Ho, et al.
Publicado: (2007)

FOLFIRI as a second-line therapy in patients with docetaxel-pretreated gastric cancer: a historical cohort
por: Maugeri-Saccà, Marcello, et al.
Publicado: (2013)

Fibrinogen Level Predicts Outcomes in Critically Ill Patients with Acute Exacerbation of Chronic Heart Failure
por: Meng, Zhongyuan, et al.
Publicado: (2021)

Preoperative low absolute lymphocyte count to fibrinogen ratio correlated with poor survival in nonmetastatic colorectal cancer
por: Huang, Xiang, et al.
Publicado: (2022)

Differential effect of MMSET mRNA levels on survival to first-line FOLFOX and second-line docetaxel in gastric cancer
por: Wei, J, et al.
Publicado: (2014)

Pretreatment Fibrinogen-Albumin Ratio (FAR) Associated with Treatment Response and Survival in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Anti-PD-1 Therapy Plus Platinum-Based Combination Chemotherapy
por: Yuan, Chengliang, et al.
Publicado: (2022)

Plasma Fibrinogen Levels as an Indicator of Myocardial Necrosis
por: Cristal, N., et al.
Publicado: (1982)

Postoperative Fasting Blood Glucose Predicts Prognosis in Stage I-III Colorectal Cancer Patients Undergoing Resection
por: Xu, Rui, et al.
Publicado: (2020)

Proposed fibrinogen standard material with purified fibrinogen for plasma fibrinogen measurement on coagulation analyser
por: Okuda, Masahiro, et al.
Publicado: (2003)

Prognostic Value of Lactate Dehydrogenase in Second-Line Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma
por: Li, Yan, et al.
Publicado: (2022)

Prenatal Plasma Fibrinogen Level Predicts Postpartum Hemorrhage of Patients With HELLP Syndrome
por: Cui, Chanjuan, et al.
Publicado: (2020)

γ' Fibrinogen as a Predictor of Survival in Amyotrophic Lateral Sclerosis
por: Pronto-Laborinho, Ana Catarina, et al.
Publicado: (2021)

Fibrinogen-to-albumin ratio predicts overall survival of hepatocellular carcinoma
por: Sun, Hao, et al.
Publicado: (2023)

The Prognostic Significance of Combined Pretreatment Fibrinogen and Neutrophil-Lymphocyte Ratio in Various Cancers: A Systematic Review and Meta-Analysis
por: Liu, Rongqiang, et al.
Publicado: (2020)

Prognostic value of pretreatment serum fibrinogen in young patients with small cell lung cancer: A cross‐sectional study
por: Tian, Juncai, et al.
Publicado: (2023)

Albumin and fibrinogen levels’ relation with orthopedics traumatic patients’ outcome after massive transfusion
por: Bazavar, Mohammadreza, et al.
Publicado: (2014)

High Plasma Fibrinogen is Correlated With Poor Response to Trastuzumab Treatment in HER2 Positive Breast Cancer
por: Liu, Yu-Lin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0s6fotdleiivc7ourkf2e708jv